Inovio Pharmaceuticals Exec Says The Ex-US Trial For COVID-19 Vaccine Candidate Is Not Impacted By The Current Phase 3 Partial Clinical Hold; Says On Track To Submit All Documents To FDA To Uplift The Clinical Hold